J2186 HCPCS Level II code: Injection, meropenem and vaborbactam, 10mg/10mg (20mg)
J2186 is the HCPCS code for “Injection, meropenem and vaborbactam, 10mg/10mg (20mg)” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2186Injection, meropenem and vaborbactam, 10mg/10mg (20mg)
Short description: Inj., meropenem, vaborbactam
HCPCS · United States
Medicare details
The indicators CMS publishes with J2186 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jan 1, 2019
Where J2186 sits
- 1J codesDrugs administered other than orally
- 2Active code J2186Injection, meropenem and vaborbactam, 10mg/10mg (20mg)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2186 mean?
J2186 is the HCPCS code for “Injection, meropenem and vaborbactam, 10mg/10mg (20mg)” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2186?
CMS lists J2186’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2186
All J codesJ2175Injection, meperidine hydrochloride, per 100 mgJ2180Injection, meperidine and promethazine hcl, up to 50 mgJ2182Injection, mepolizumab, 1 mgJ2183Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mgJ2184Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mgJ2185Injection, meropenem, 100 mgJ2210Injection, methylergonovine maleate, up to 0.2 mgJ2212Injection, methylnaltrexone, 0.1 mgJ2246Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mgJ2247Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mgJ2248Injection, micafungin sodium, 1 mgJ2249Injection, remimazolam, 1 mg